Log In
Print
BCIQ
Print
Print this Print this
 

GNX-5086

  Manage Alerts
Collapse Summary General Information
Company Genextra S.p.A.
DescriptionSmall molecule inhibitor of mitochondrial permeability transition pore (mPTP)
Molecular Target Mitochondrial permeability transition pore (mPTP)
Mechanism of ActionMitochondrial inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMyocardial infarction (MI)
Indication DetailsTreat cardiac reperfusion injury that contributes significantly to the morbidity and mortality subsequent to myocardial infarction (MI)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today